The role of inflammatory biomarkers in advanced non-small cell lung cancer patients treated with chemo-immunotherapy

被引:0
|
作者
Zattarin, E. [1 ]
Manglaviti, S. [1 ]
Galli, E. [1 ]
Apollonio, G. [1 ]
Beninato, T. [1 ]
Mazzeo, L. [1 ]
Massa, G. [1 ]
Bottiglieri, A. [1 ]
Ganzinelli, M. [1 ]
Proto, C. [1 ]
Ferrara, R. [1 ]
Prelaj, A. [1 ]
Galli, G. [1 ]
De Toma, A. [1 ]
Brambilla, M. [1 ]
Occhipinti, M.
Garassino, M. C. C. [2 ]
De Braud, F. G. M. [1 ]
Lo Russo, G. [1 ]
机构
[1] Ist Nazl Tumori Milano Fondazione IRCCS, Dept Oncol Med, Milan, Italy
[2] Univ Chicago, Dept Hematol Oncol, Chicago, IL USA
关键词
D O I
10.1016/j.annonc.2021.08.1913
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1311P
引用
收藏
页码:S1010 / S1011
页数:2
相关论文
共 50 条
  • [31] Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Joy
    Reckamp, Karen L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 400 - 408
  • [32] Incidence of venous thromboembolism and association with PD-L1 expression in advanced non-small cell lung cancer patients treated with first-line chemo-immunotherapy
    De Azevedo, Liliana Aguiar
    Orione, Charles
    Tromeur, Cecile
    Couturaud, Francis
    Descourt, Renaud
    Geier, Margaux
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [33] Predictive score using clinical and blood biomarkers in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapy
    Prelaj, A.
    Rebuzzi, S. E.
    Pizzutilo, P.
    Montrone, M.
    Pesola, F.
    Longo, V.
    Lapadula, V.
    Cassano, F.
    Petrillo, P.
    Bafunno, D.
    Varesano, N.
    Lamorgese, V.
    Mastrandrea, A.
    Ricci, D.
    Catino, A.
    Domenico, G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] Characterizing the tumor microbiome of non-small cell lung cancer patients receiving neoadjuvant chemo-immunotherapy (SAKK 16/14)
    Boesch, Maximilian
    Baty, Florent
    Rothschild, Sacha
    Alborelli, Ilaria
    Keller, Eveline
    Savic, Spasenija
    Hayoz, Stefanie
    Joerger, Markus
    Fruh, Martin
    Brutsche, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [35] Peripheral CD4+ T cells correlate with response and survival in patients with advanced non-small cell lung cancer receiving chemo-immunotherapy
    Yang, Xin
    Li, Qiao
    Zeng, Tianyang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [36] Immunological Biomarkers Characterization in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemo-Radiotherapy
    Saigi, M.
    Baixeras, N.
    Rullan, A.
    Bergamino Sirven, M.
    Navarro-Martin, A.
    Arnaiz, M.
    Ruffinelli, J. C.
    Mesia, C.
    Palmero, R.
    Padrones, S.
    Cardenal, F.
    Sanchez-Cespedes, M.
    Nadal, E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2155 - S2155
  • [37] Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer
    Chen, Yulong
    Zhang, Lianmin
    Yan, Bo
    Zeng, Ziqing
    Hui, Zhenzhen
    Zhang, Ran
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 761 - 767
  • [38] Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy
    Zattarin, Emma
    Manglaviti, Sara
    Apollonio, Giulia
    Beninato, Teresa
    Mazzeo, Laura
    Massa, Giacomo
    Bottiglieri, Achille
    Galli, Edoardogregorio
    De Toma, Alessandro
    Occhipinti, Mario
    Brambilla, Marta
    Ferrara, Roberto
    Ganzinelli, Monica
    Proto, Claudia
    Garassino, Marina Chiara
    de Braud, Filippo
    Lo Russo, Giuseppe
    Prelaj, Arsela
    FUTURE ONCOLOGY, 2022, 18 (23) : 2593 - 2604
  • [39] CHEMO-IMMUNOTHERAPY OF NON-SMALL CELL LUNG-CANCER (NSCLC) WITH OR WITHOUT THYMOSIN FRACTION-V IMMUNOTHERAPY (T)
    VALDIVIESO, M
    BEDIKIAN, AY
    PATT, Y
    MURPHY, WK
    UMSAWASDI, T
    CARR, DT
    HERSH, EM
    BODEY, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 495 - 495
  • [40] Biomarkers for immunotherapy resistance in non-small cell lung cancer
    Rother, Catriona
    John, Tom
    Wong, Annie
    FRONTIERS IN ONCOLOGY, 2024, 14